Estimating the value of intravenous calcium and magnesium in ameliorating oxaliplatin-induced neuropathy

Journal of Clinical Oncology

Volumn 32, Issue 29, 2014, Pages 3341-

  Atkins, Carl D ^a  

^a St Peter's Hospital Albany   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCONATE CALCIUM; MAGNESIUM SULFATE; OXALIPLATIN; ANTINEOPLASTIC AGENT; CALCIUM; MAGNESIUM; NEUROPROTECTIVE AGENT; PLATINUM COMPLEX;

CANCER CHEMOTHERAPY; CANCER PATIENT; COLORECTAL CANCER; COMBINATION CHEMOTHERAPY; DRUG INDUCED DISEASE; HUMAN; LETTER; NEUROTOXICITY; OXALIPLATIN INDUCED NEUROPATHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); ADENOCARCINOMA; COLONIC NEOPLASMS; FEMALE; MALE; NEUROTOXICITY SYNDROMES; PERIPHERAL NERVOUS SYSTEM DISEASES; SENSATION DISORDERS;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CALCIUM; CALCIUM GLUCONATE; COLONIC NEOPLASMS; FEMALE; HUMANS; MAGNESIUM; MAGNESIUM SULFATE; MALE; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; ORGANOPLATINUM COMPOUNDS; PERIPHERAL NERVOUS SYSTEM DISEASES; SENSATION DISORDERS;

EID: 84907500490     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.56.5424     Document Type: Letter

References (5)

1. Loprinzi CL, Qin R, Dakhil SR, et al: Phase III randomized, placebocontrolled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance). J Clin Oncol 32:997-1005, 2014
2. Grothey A, Nikcevich DA, Sloan JA, et al: Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7. J Clin Oncol 29:421-427, 2011
3. Colton T: Statistics in Medicine. Boston, MA, Little, Brown, 1974, pp 151-188
4. Wilcox RA, Djulbegovic B, Moffitt HL, et al: Randomized trials in oncology stopped early for benefit. J Clin Oncol 26:18-19, 2008
5. Freiman JA, Chalmers TC, Smith H Jr, et al: The importance of beta, the type II error, and sample size in the design and interpretation of the randomized controlled trial: Survey of two sets of "negative" trials, in Bailar JC III, Mosteller F (eds): Medical Uses of Statistics (ed 2).. Boston, MA, Massachusetts Medical Society, 1992, pp 357-373.